ESC Professional Premium Access

Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis

Congress Presentation

About the speakers

Professor Thomas Modine

CHU Bordeaux, Bordeaux (France)
6 presentations
1 follower

Professor Nicolas van Mieghem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
19 presentations

6 more presentations in this session

Biological versus mechanical SAVR patient's age threshold: PARTNER II study influenced real world practice in a large French cohort.

Speaker: Doctor Y. Chabry (Paris, FR)


Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement

Speaker: Doctor I. Fialho (Lisbon, PT)


Early mitral valve repair surgery versus active surveillance in patients with asymptomatic severe primary mitral regurgitation; insights from the Dutch AMR registry

Speaker: Doctor S. El Mathari (Amsterdam, NL)


Elderly patients with severe aortic stenosis - does moderate mitral regurgitation require simultaneous surgical intervention?

Speaker: Doctor A. Kwiecien (Zabrze, PL)


Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation

Speaker: Doctor S. Kazum (Petah Tikva, IL)


Access the full session

New insights around surgical valve replacement

Speakers: Professor T. Modine, Professor N. van Mieghem, Doctor Y. Chabry, Doctor I. Fialho, Doctor S. El Mathari...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb